Prevention of xanthine stone formation by augmented dose of allopurinol in the Lesch-Nyhan syndrome.
D000293:Adolescent; D000493:Allopurinol / Q000627:therapeutic use*; D002137:Calculi / Q000032:analysis / Q000517:prevention & control*; D006801:Humans; D007926:Lesch-Nyhan Syndrome / Q000188:drug therapy*; D008297:Male; D019820:Xanthine; D014970:Xanthines / Q000032:analysis
D014970:Xanthines; D019820:Xanthine; D000493:Allopurinol